Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation

British Journal of Anaesthesia

Volumn 97, Issue 5, 2006, Pages 681-686

  de Boer, H D ^a,c   van Egmond, J ^a   van de Pol, F ^a   Bom, A ^b   Driessen, J J ^a   Booij, L H D J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Pharmacology ^*  (United Kingdom)

^c MARTINI HOSPITAL   (Netherlands)

Author keywords

Neuromuscular block; Reversal agent; Rocuronium; Sugammadex (Org 25969); Time course of action

Indexed keywords

GAMMA CYCLODEXTRIN DERIVATIVE; ROCURONIUM; SUGAMMADEX;

ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MECHANISM; ENCAPSULATION; MATHEMATICAL MODEL; MEDICAL RESEARCH; MUSCLE TWITCH; NEUROMUSCULAR BLOCKING; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; TIME;

EID: 33750129085     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/ael240     Document Type: Article

References (10)

1. Bom A, Bradley M, Cameron K, et al. A novel concept of reversing neuromuscular block chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl 2002; 41: 266-70
2. Hayes AH, Mirakhur RK, Breslin DS, et al. Post operative residual block after intermediate acting neuromuscular blocking drugs. Anesthesia 2001; 56: 312-18
3. Booij LHDJ, De Boer HD, Van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Periop Med Pain 2002; 21: 92-8
4. De Boer HD, van Egmond J, van de Pol F, et al. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: Reversal of neuromuscular block in anaesthestized Rhesus monkeys. Br J Anaesth 2006; 96: 201-6
5. De Boer HD, van Egmond J, van de Pol F, et al. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. Br J Anaesth 2006; 96: 473-9
6. De Boer HD, van Egmond J, van de Pol F, et al. Reversal of profound rocuronium neuromuscular blockade by sugammadex in anesthetized Rhesus monkeys. Anesthesiology 2006; 104: 718-23
7. Gijsenberg F, Ramael S, De Bruyn S, et al. Preliminary assessment of Org 25969 as a reversal agent for rocuronium in healthy male volunteers. Anesthesiology 2005; 103: 695-703
8. -1) neuromuscular block by Org 25969: A multi center dose finding, safety study. Anesthesiology 2005; 103: A1117
9. Shields M, Mirakhur RK, Moppett I, et al. Org 25969 (sugamadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth 2006; 96: 36-43
10. Epemolu O, Mayer I, Hope F, et al. Liquid chromatography/mass spectrometric bioanalysis of a modified γ-cyclodextrin (Org 25969), rocuronium bromide (Org 9426) in guinea pig plasma and urine: Its application to determine the plasma pharmacokinetics of Org 25969. Rapid Commun Mass Spectrom 2002; 16: 1946-52